SyntheticMR’s software solution SyMRI receives regulatory approval in Japan

STOCKHOLM, Sept. 3, 2020 /PRNewswire/ — “We are proud to bring our SyMRI software to the Japanese market” says Ulrik Harrysson, CEO, SyntheticMR. “We have an established customer base in Japan currently using the product for research. Now we are excited to be able to offer SyMRI for clinical use on the Japanese market. We know there are many healthcare providers that are looking forward to utilize our technology to speed up their current workflow and add additional information to aid in diagnosis.”

SyMRI provides multiple contrast weighted images and quantitative information about the patient in a single 5-6-minute scan, enabling users to speed up their imaging workflow and add objective decision support to their practice. 

CONTACT:

For additional information, please contact Ulrik Harrysson, CEO, SyntheticMR AB, +46 70 529 29 87 ulrik.harrysson@syntheticmr.com.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/syntheticmr-ab/r/syntheticmr-s-software-solution-symri-receives-regulatory-approval-in-japan,c3188143

The following files are available for download:

 

 

 

View original content:http://www.prnewswire.com/news-releases/syntheticmrs-software-solution-symri-receives-regulatory-approval-in-japan-301123724.html

SOURCE SyntheticMR AB

Staff

Recent Posts

Daily Fit Notes Rolls Out Affordable Fitness Solutions for the Modern Lifestyle

Daily Fit Notes, founded by Justin Brey in New York, launches a text-based subscription fitness…

2 days ago

WillowWood Rebrand by DD.NYC Wins Gold Anthem Award for Product and Innovation in 2024 Rebrand

MT. STERLING, Ohio, Dec. 20, 2024 /PRNewswire/ -- WillowWood, a global leader in prosthetic solutions,…

2 days ago

Quantum Biopharma Announces Closing of Second Tranche

TORONTO, ON / ACCESSWIRE / December 20, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma"…

2 days ago

Glow Lifetech Announces Completion of Final Payment under Swiss Pharma Share Exchange Agreement and Debt Settlement

Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink:…

2 days ago